Clinical Trial Update: Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating toripalimab in combination with cryoablation as first-line therapy for driver-negative advanced non-small cell lung …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING